CANNAFEN Trademark
CANNAFEN is a USPTO trademark filed by Senzer Limited. Status: Registered.
Trademark Facts
| Mark | CANNAFEN |
|---|---|
| Serial Number | 79246444 |
| Registration Number | 6077024 |
| Status | Registered |
| Filing Date | 2018-10-05 |
| Registration Date | 2020-06-16 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Senzer Limited |
| Prosecution Events | 49 |
| Latest Event | WOAR on 2023-09-14 |
Goods & Services
Pharmaceutical preparations for inhalers for the treatment of pain, neuropathy, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; pharmaceutical preparations and substances for use in chemotherapy; pharmaceutical preparations for inhalers for the treatment of pain, neuropathy, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; drug delivery agents in the nature of tablets, liquid medications, inhalers, nasal and oral sprays that facilitate the delivery of a wide range of pharmaceuticals; Transdermal patches and transdermal patches for medical treatment, both for the treatment of pain, neuropathy, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; all of the aforementioned goods containing cannabis that is solely synthetic in nature; sanitary preparations for medical purposes, vaccines, and sanitary sterilising preparations, all not containing cannabis or CBD | Inhalers for medical purposes; medical inhalers; inhalers for medical use; inhalers for therapeutic use; therapeutic inhalers; inhalers for medical purposes, sold empty; all of the aforementioned goods either exclusively for use with cannabis that is solely synthetic in nature, or containing cannabis that is solely synthetic in nature